Literature DB >> 5321849

Clinical evaluation of the antihypertensive effects of debrisoquin, a new postganglionic vasodepressor agent.

F J Talbot.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1965        PMID： 5321849

Source DB:  PubMed          Journal:  Med Ann Dist Columbia        ISSN： 0025-6986


× No keyword cloud information.
  1 in total

1.  3,4-Dehydrodebrisoquine, a novel debrisoquine metabolite formed from 4-hydroxydebrisoquine that affects the CYP2D6 metabolic ratio.

Authors:  Yueying Zhen; Ondrej Slanar; Kristopher W Krausz; Chi Chen; Josef Slavík; Kerry L McPhail; T Mark Zabriskie; Frantisek Perlík; Frank J Gonzalez; Jeffrey R Idle
Journal:  Drug Metab Dispos       Date:  2006-06-16       Impact factor: 3.922
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.